Actively Recruiting
Longitudinal Screening for Financial Hardship to Improve Outcomes in Patients With Advanced Cancer
Led by Alliance Foundation Trials, LLC. · Updated on 2026-05-12
1000
Participants Needed
7
Research Sites
195 weeks
Total Duration
On this page
Sponsors
A
Alliance Foundation Trials, LLC.
Lead Sponsor
M
Memorial Sloan Kettering Cancer Center
Collaborating Sponsor
AI-Summary
What this Trial Is About
The study aims to determine whether monthly remote digital financial hardship screening among adults with advanced/metastatic cancer, undergoing outpatient systemic therapy with non-curative intent, improves patient-centered outcomes, including financial worry, health-related quality of life (HRQoL), symptom burden, patient-reported cancer treatment adherence, and exploratory outcomes of overall survival, patient-reported economic burden, patient-reported support received, patient-reported financial coping strategies, and health insurance literacy.
CONDITIONS
Official Title
Longitudinal Screening for Financial Hardship to Improve Outcomes in Patients With Advanced Cancer
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Minimum age of 21
- Understands English and/or Spanish
- Has a diagnosis of advanced/metastatic cancer
- Currently undergoing systemic therapy (enteral or parenteral) with non-curative intent
- Has been receiving treatment for at least 2 months
- Life expectancy of at least 6 months, in the opinion of the treating oncologist
- Cognitively able to give informed consent
You will not qualify if you...
- Under the age of 21
- Does not understand English or Spanish
- Has cognitive deficits that would preclude understanding of consent form and/or questionnaires
- Undergoing treatment with curative intent (e.g., adjuvant chemotherapy for breast, lung, or ovarian cancer, primary curative therapy for testis cancer or lymphoma)
- Not undergoing systemic therapy (enteral or parenteral) with non-curative intent
- Receiving treatment for fewer than 2 months
- Life expectancy is less than 6 months, in the opinion of the treating oncologist
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 7 locations
1
Dignity Health
Phoenix, Arizona, United States, 85004
Actively Recruiting
2
New Hampshire Oncology-Hematology, PA
Concord, New Hampshire, United States, 03301
Actively Recruiting
3
Solinsky Center for Cancer Care
Manchester, New Hampshire, United States, 03103
Actively Recruiting
4
New York City Health and Hospitals
New York, New York, United States, 10004
Actively Recruiting
5
Sanford Health
Fargo, North Dakota, United States, 58102
Actively Recruiting
6
Gibbs Cancer Center
Spartanburg, South Carolina, United States, 29303
Actively Recruiting
7
Pan American Center for Oncology Trials
San Juan, Puerto Rico, 00935
Actively Recruiting
Research Team
A
AFT Quality Management Group Inbox
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
HEALTH_SERVICES_RESEARCH
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here